ClinicalTrials.gg
CompletedNCT05281653Updated Nov 5, 2024

The Effect of Neuromuscular Training Program in Futsal Players

An interventional study of Neuromuscular exercise Training and Routine training sessions in Sports Physical Therapy, sponsored by Medipol University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-05.

Sponsored by Medipol University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
Male
01

Study summary

Despite its popularity, there has been limited research on futsal, possibly due to the lack of financial interest in the game, and most of these research articles have addressed game analysis and/or physiological demands on players during match playing and training. For this reason, our aim is to evaluate the effectiveness of an 8-week neuromuscular training program on performance, physical fitness and injury risk in university futsal players.

Read the detailed description

Futsal, known as five-on-five indoor soccer, is a team sport officially authorized by FIFA and is becoming more and more popular all over the world. Futsal is among the 10 risky sports with the highest traumatic injuries. Futsal-induced traumas cause undesirable consequences such as accelerated osteoarthritis, different types of injuries in the muscle-tendon region, ligament injuries, cartilage injuries, loss of physical activity and higher repetitive injuries. Activities that result in a higher level of fitness can significantly reduce the likelihood of injury and serve as a useful tool for athletes' professional careers and post-career periods.

Neuromuscular control, which is considered a critical component of motor skills, is defined as the ability to keep the body's center of gravity within the base of support. It can be categorized as static or dynamic balance and may be the most modifiable risk factor for the prevention of knee injuries. Interventions targeting neuromuscular control include dynamic lower extremity alignment during landing from a jump, shock absorption, muscle recruitment patterns; and gains improvement in balance through plyometric, strengthening, balancing, endurance and stability exercises. Neuromuscular training program can improve neuromuscular control, which can lead to improvement in balance and joint stability.

In our study, it was aimed to evaluate the effectiveness of an 8-week neuromuscular training program on performance, physical fitness and injury risk in university futsal players.

02

Conditions studied

  • Sports Physical Therapy

Keywords

  • futsal
  • neuromuscular training program
  • performance
  • physical fitness
  • risk of injury
03

In context

Lead sponsor

Medipol University is the lead sponsor of 320 studies on the registry; 87 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Playing in Istanbul Medipol University futsal team
  • 2 days a week, 2 hours training for futsal or 1 game a week and 2 hours a week, 2 days a week

Exclusion criteria

Exclusion Criteria:

  • History of lower extremity injury or surgery within 6 months prior to the test
  • Injury three months before the study,
  • Failure to heal or complete rehabilitation of previous injury,
  • Physical or mental conditions that prevent them from participating in technical and tactical futsal training and/or experimental training programs
  • Two or more missed training sessions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Neuromuscular Training Group

    Athletes in this group will receive progressive neuromuscular exercise training in addition to routine 2 weekly training sessions.

    Behavioral: Neuromuscular exercise Training

  • Experimental
    Control Group

    The routine will continue with 2 workouts per week.

    Behavioral: Routine training sessions

Interventions

  • BehavioralNeuromuscular exercise Training

    Progressive neuromuscular exercise training

  • BehavioralRoutine training sessions

    Routine training sessions

06

What researchers measure

Primary outcomes

  1. The Tuck Jump Test

    It is used to monitor changes in dynamic lower extremity biomechanics. In the evaluation; knee, foot, hip and jump biomechanics will be controlled over 10 parameters. Biomechanical changes during the test will be analyzed with the Kinovea program.

    Time frame: 0-8 weeks

  2. Horizontal Jumping Test

    Athletes will jump as far as possible with their feet shoulder-width apart, using their arms in the horizontal direction, and the distance between the starting point and the heel of the foot will be measured and recorded

    Time frame: 0-8 weeks

  3. Countermovement Jumping Test

    It will be used to test the explosive strength of the lower extremity. Participants will perform 3 vertical jumps with their hands on the hips with maximum effort and the best score will be analyzed using the Kinovea program.

    Time frame: 0-8 weeks

  4. Sprint Acceleration Test

    In this test, which is used to measure the acceleration abilities of the athletes, the athletes will start from 0.3 m behind the starting line on a 10 m field and perform a linear sprint with maximum effort 2 times with a 1 minute rest. The shortest time will be kept and recorded with the stopwatch.

    Time frame: 0-8 weeks

  5. Repeated Sprint Test (RST)

    The 40m RST test consists of 8x40m sprints separated by 20 seconds of passive recovery. Athletes will be asked to warm up first with a 5-minute progressive run and then to run as fast as possible between 2 lines spaced 20 m apart. The athlete will start 0.5 m behind the starting line and the times will be recorded using a stopwatch. Each participant will run 10 m from the start/finish line of the track, turn 180 degrees, then run 20 m to the other end of the track, turn 180 degrees, and finally run 10 m back from the start/finish line. After each sprint, the athletes will slow down and start ready for the next sprint. They will walk the line. Best (RSTenibest) and average sprint time (RSTort) will be recorded as performance indexes

    Time frame: 0-8 weeks

  6. Y Balance Test

    In the Y balance test, the letter Y is drawn on the ground. Of the 3 determined lines, 2 back lines form an angle of 135 degrees with the front line. During the test, for the dominant and non-dominant legs, individuals try to maintain their balanced stance on one leg by reaching in 3 directions (anterior - postero-medial and postero-lateral) with each leg, and the distances reached are measured by fixing a tape measure on the floor.

    Time frame: 0-8 weeks

  7. Korebalance® System

    It is a computerized balance and exercise system that offers a high-tech option for balance assessment. It has a variable air pressure system and a tilt sensor under the platform to monitor 360-degree horizontal and 20-degree vertical movements. The software of the system gives an evaluation score following the static and dynamic balance evaluations. Higher scores indicate more balance disorders.

    Time frame: 0-8 weeks

07

Study locations

1 site
  • Istanbul Medipol University
    Istanbul, Turkey (Türkiye)
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2022 to primary completion in Oct 2024, 31 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 7, 2022
First posted
Mar 16, 2022
StartActual
Mar 14, 2022
Primary completionActual
Oct 24, 2024
CompletionActual
Nov 4, 2024
Last update
Nov 5, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05281653
Lead sponsor
Medipol University
Responsible party
Gülay Aras (Principal Investigator, Medipol University) — Principal investigator
First posted
Mar 16, 2022
Start date
Mar 14, 2022
Primary completion
Oct 24, 2024
Completion
Nov 4, 2024
Last update
Nov 5, 2024

Study contacts

Gülay Aras Bayram, PhD
principal investigator · Medipol University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion